311 related articles for article (PubMed ID: 17092346)
1. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
Vogt F; Hall S; Marteau TM
BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
[TBL] [Abstract][Full Text] [Related]
2. General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies.
Vogt F; Hall S; Marteau TM
BMC Fam Pract; 2007 Jul; 8():39. PubMed ID: 17615061
[TBL] [Abstract][Full Text] [Related]
3. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.
Vogt F; Hall S; Marteau TM
Nicotine Tob Res; 2008 Aug; 10(8):1405-13. PubMed ID: 18686189
[TBL] [Abstract][Full Text] [Related]
4. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
McEwen A; West R; Owen L
Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
[TBL] [Abstract][Full Text] [Related]
5. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Etter JF; Schneider NG
Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
[TBL] [Abstract][Full Text] [Related]
6. General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
McEwen A; West R; Owen L
BMC Fam Pract; 2001; 2():6. PubMed ID: 11701091
[TBL] [Abstract][Full Text] [Related]
7. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
[TBL] [Abstract][Full Text] [Related]
8. U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy.
Herbert R; Coleman T; Britton J
Nicotine Tob Res; 2005 Aug; 7(4):541-6. PubMed ID: 16085525
[TBL] [Abstract][Full Text] [Related]
9. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
Kotz D; Wagena EJ; Wesseling G
Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' views on and referral to NHS smoking cessation services.
McEwen A; West R; Owen L; Raw M
Public Health; 2005 Apr; 119(4):262-8. PubMed ID: 15733685
[TBL] [Abstract][Full Text] [Related]
11. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Bertram MY; Lim SS; Wallace AL; Vos T
Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
[TBL] [Abstract][Full Text] [Related]
12. Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey.
Steinberg MB; Delnevo CD
J Gen Intern Med; 2007 Oct; 22(10):1459-62. PubMed ID: 17726636
[TBL] [Abstract][Full Text] [Related]
13. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Szatkowski L; Coleman T; McNeill A; Lewis S
Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
[TBL] [Abstract][Full Text] [Related]
14. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
Paul CL; Tzelepis F; Walsh RA; Turner R
Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
[TBL] [Abstract][Full Text] [Related]
16. Smoking cessation and nicotine replacement therapy in current primary maternity care.
Pullon S; Webster M; McLeod D; Benn C; Morgan S
Aust Fam Physician; 2004; 33(1-2):94-6. PubMed ID: 14988974
[TBL] [Abstract][Full Text] [Related]
17. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
[TBL] [Abstract][Full Text] [Related]
18. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Lutsenko H; Doran CM; Hall WD
Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
20. Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban.
Durkin S; Wakefield M; Spittal M
Addict Behav; 2006 Dec; 31(12):2158-68. PubMed ID: 16567056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
